APA (7th ed.) Citation

Wilder, J. M., Jeffers, L. J., Ravendhran, N., Shiffman, M. L., Poulos, J., Sulkowski, M. S., . . . Reddy, K. R. (2016). Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data. Hepatology (Baltimore, Md.), 63(2), 437-444. https://doi.org/10.1002/hep.28334

Chicago Style (17th ed.) Citation

Wilder, Julius M., et al. "Safety and Efficacy of Ledipasvir‐sofosbuvir in Black Patients with Hepatitis C Virus Infection: A Retrospective Analysis of Phase 3 Data." Hepatology (Baltimore, Md.) 63, no. 2 (2016): 437-444. https://doi.org/10.1002/hep.28334.

MLA (9th ed.) Citation

Wilder, Julius M., et al. "Safety and Efficacy of Ledipasvir‐sofosbuvir in Black Patients with Hepatitis C Virus Infection: A Retrospective Analysis of Phase 3 Data." Hepatology (Baltimore, Md.), vol. 63, no. 2, 2016, pp. 437-444, https://doi.org/10.1002/hep.28334.